,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['breast', 'destiny-breast04', 'daiichisankyous', 'astrazenecaus', 'astrazeneca']
attending #asco22? join us as we present the highly anticipated destiny-breast04 phase iii trial data in certain patients with her2-low metastatic #breastcancer with our collaborators . 
The official Twitter feed for AstraZeneca US. For more info visit http://t.co/5VlUaVGyiC.